Clinical Trial Update: Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

View source ↗

Summary

A clinical trial is actively recruiting to study cardiovascular health and risk factors in transgender individuals undergoing gender-affirming treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Gender Dysphoria

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Gender Incongruence, Cardiovascular (CV) Risk | Status: RECRUITING